News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi-Aventis (France) (SASY.PA) Ends Research on Troubled Diet Drug, Accomplia


11/5/2008 2:34:18 PM

TRENTON, N.J. - French drugmaker Sanofi-Aventis is halting all research on a once-promising diet drug that never made it to the U.S. market.

Read at Forbes
Read at Wall Street Journal
Read at Bloomberg
Read at Washington Post


comments powered by Disqus
   
Obesity

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES